Free Trial

This company has been marked as potentially delisted and may not be actively trading.

resTORbio (TORC) Competitors

resTORbio logo

TORC vs. WHWK, VIRI, PYRGF, VHAQ, AADI, OSTX, NBRV, ATNM, EGRX, and ELYM

Should you be buying resTORbio stock or one of its competitors? The main competitors of resTORbio include Whitehawk Therapeutics (WHWK), Virios Therapeutics (VIRI), PyroGenesis Canada (PYRGF), Viveon Health Acquisition (VHAQ), Aadi Bioscience (AADI), OS Therapies (OSTX), Nabriva Therapeutics (NBRV), Actinium Pharmaceuticals (ATNM), Eagle Pharmaceuticals (EGRX), and Eliem Therapeutics (ELYM).

resTORbio vs. Its Competitors

resTORbio (NASDAQ:TORC) and Whitehawk Therapeutics (NASDAQ:WHWK) are both small-cap pharmaceutical preparations industry companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, earnings, profitability and institutional ownership.

resTORbio has a beta of 2.43, indicating that its stock price is 143% more volatile than the S&P 500. Comparatively, Whitehawk Therapeutics has a beta of 0.55, indicating that its stock price is 45% less volatile than the S&P 500.

In the previous week, Whitehawk Therapeutics had 1 more articles in the media than resTORbio. MarketBeat recorded 1 mentions for Whitehawk Therapeutics and 0 mentions for resTORbio. Whitehawk Therapeutics' average media sentiment score of 1.89 beat resTORbio's score of 0.00 indicating that Whitehawk Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
resTORbio Neutral
Whitehawk Therapeutics Very Positive

Whitehawk Therapeutics has higher revenue and earnings than resTORbio. resTORbio is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
resTORbioN/AN/A-$82.74M-$2.41-0.31
Whitehawk Therapeutics$25.98M3.46-$63.69M$0.1611.94

Whitehawk Therapeutics has a net margin of 99.42% compared to resTORbio's net margin of 0.00%. Whitehawk Therapeutics' return on equity of -56.73% beat resTORbio's return on equity.

Company Net Margins Return on Equity Return on Assets
resTORbioN/A -78.12% -71.63%
Whitehawk Therapeutics 99.42%-56.73%-48.68%

46.2% of resTORbio shares are owned by institutional investors. Comparatively, 52.1% of Whitehawk Therapeutics shares are owned by institutional investors. 11.8% of resTORbio shares are owned by insiders. Comparatively, 49.9% of Whitehawk Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Whitehawk Therapeutics beats resTORbio on 10 of the 11 factors compared between the two stocks.

Get resTORbio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TORC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TORC vs. The Competition

MetricresTORbioPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$27.32M$839.03M$5.60B$9.11B
Dividend YieldN/A4.84%5.24%4.02%
P/E Ratio-0.411.1727.9620.25
Price / SalesN/A241.37430.5799.61
Price / CashN/A17.6937.4658.16
Price / Book0.336.528.045.49
Net Income-$82.74M-$23.68M$3.18B$250.27M

resTORbio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TORC
resTORbio
N/A$0.75
+1.3%
N/A-41.7%$27.32MN/A-0.41N/AGap Down
WHWK
Whitehawk Therapeutics
N/A$1.99
+0.5%
N/AN/A$93.28M$25.98M0.0040Gap Down
VIRI
Virios Therapeutics
N/A$4.80
-0.6%
$5.00
+4.2%
+1,936.7%$92.44MN/A-17.785
PYRGF
PyroGenesis Canada
0.0929 of 5 stars
$0.35
-2.5%
N/A-55.0%$64.48M$9.14M-5.7690News Coverage
Gap Down
VHAQ
Viveon Health Acquisition
N/A$11.00
flat
N/AN/A$62.26MN/A0.002High Trading Volume
AADI
Aadi Bioscience
0.4713 of 5 stars
$1.98
-0.5%
$1.67
-15.8%
+31.3%$48.90M$25.07M-0.8740
OSTX
OS Therapies
1.7059 of 5 stars
$1.62
-6.4%
$18.00
+1,011.1%
N/A$45.52MN/A-1.88N/ANews Coverage
NBRV
Nabriva Therapeutics
N/AN/AN/AN/A$45.46M$35.59M0.0070
ATNM
Actinium Pharmaceuticals
2.8186 of 5 stars
$1.43
+0.7%
$4.00
+179.7%
N/A$44.61MN/A-1.0330News Coverage
Positive News
EGRX
Eagle Pharmaceuticals
2.4524 of 5 stars
$3.25
+8.3%
N/A-41.1%$42.21M$257.55M0.00100News Coverage
Gap Down
ELYM
Eliem Therapeutics
N/A$1.28
+1.6%
N/A-80.9%$38.08MN/A-2.429

Related Companies and Tools


This page (NASDAQ:TORC) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners